28744-92-5 Usage
Uses
Used in Organic Synthesis:
(5Z)-5-[(3-bromophenyl)methylidene]imidazolidine-2,4-dione is used as an intermediate in the synthesis of various organic compounds. Its unique structure, which includes a bromophenyl group, allows for a range of chemical reactions and modifications, making it a valuable building block in the creation of new molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (5Z)-5-[(3-bromophenyl)methylidene]imidazolidine-2,4-dione is used as a potential pharmaceutical compound. Its structural features may contribute to the development of new drugs, particularly those targeting specific biological pathways or receptors. Further research and study are required to fully understand its potential applications and effectiveness in this area.
Used in Pharmaceutical Research:
(5Z)-5-[(3-bromophenyl)methylidene]imidazolidine-2,4-dione is also used as a subject of pharmaceutical research. Its properties and reactivity may provide insights into the design and development of new drugs, as well as the understanding of molecular interactions and mechanisms of action. (5Z)-5-[(3-bromophenyl)methylidene]imidazolidine-2,4-dione could serve as a starting point for the creation of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 28744-92-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,7,4 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 28744-92:
(7*2)+(6*8)+(5*7)+(4*4)+(3*4)+(2*9)+(1*2)=145
145 % 10 = 5
So 28744-92-5 is a valid CAS Registry Number.
28744-92-5Relevant academic research and scientific papers
SHIKIMATE PATHWAY INHIBITORS AND THE USE THEREOF
-
Paragraph 0041;0042, (2015/05/26)
The present invention relates to methods of inhibiting shikimate pathway, comprising administering to a subject a pharmaceutically acceptable composition comprising a compound having a formula: or pharmaceutically acceptable salts thereof. The present invention also provides a synergistic antibacterial composition containing compound
